CBP-1008
Ovarian Cancer (including Clear Cell Carcinoma)
Pivotal TrialsActive
Key Facts
Indication
Ovarian Cancer (including Clear Cell Carcinoma)
Phase
Pivotal Trials
Status
Active
Company
About Coherent Biopharma
A clinical-stage biotech company developing bi-targeting XDC drugs to treat cancer and address undruggable targets.
View full company profile